This compound is a pharmaceutical intermediate featuring a pyrimidinedione ring substituted with chlorine and a fluorobenzonitrile moiety. It is primarily used in the synthesis of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
1H-Imidazole-1-ethanamine, 4-amino-N-(2,2-dimethylpropyl)-beta,beta-dimethyl-
pharmaceutical intermediate
[(1S,3S)-3-[[4-Methoxy-3-(3-methoxypropoxy)phenyl]methyl]-4-methyl-1-[(2S,4S)-tetrahydro-4-(1-methylethyl)-5-oxo-2-furanyl]pentyl]carbamic acid tert-butyl ester
pharmaceutical intermediate
2-(Chloromethyl)-4-methoxy-3-methylpyridine hydrochloride
pharmaceutical intermediate
2-Chloromethyl-4-methoxy-3,5-dimethylpyridine hydrochloride
pharmaceutical intermediate
2-[(6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]benzonitrile
pharmaceutical intermediate
2-[(6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]-benzonitrile-d3
pharmaceutical raw material
2-((6-Chloro-3-ethyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
pharmaceutical intermediate
1-{[2-Fluoro-6-(trifluoromethyl)phenyl]methyl}-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione
pharmaceutical intermediate
2-[(6-chloro-3-methyl-2,4-dioxopyrimidin-1-yl)methyl]-4-fluorobenzonitrile
DNCGCZRILRRTMK-UHFFFAOYSA-N
CN1C(=O)C=C(N(C1=O)CC2=C(C=CC(=C2)F)C#N)Cl
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.